PMID: 3856733Jan 1, 1985Paper

Pneumococcal vaccination in children with acute lymphocytic leukemia

Medical and Pediatric Oncology
S FeldmanG Schiffman

Abstract

Sixty-three children with ALL in CCR and treated according to a standard therapy protocol were immunized with the 14-valent pneumococcal vaccine. Forty-six children were vaccinated 1, 3, or 6 months following initial induction remission; 15 were vaccinated 4-6 weeks following successful completion of 30 months of antileukemia therapy; and two were vaccinated at the time of diagnosis. Response to the vaccine was suboptimal and by the 6-month follow-up there were only two serotypes for which more than half the patients tested had greater than or equal to 300 ng antibodies N/ml.

References

Nov 1, 1979·Pediatric Clinics of North America·D W TeeleJ O Klein
Jan 1, 1976·International Journal of Radiation Oncology, Biology, Physics·W T Hughes
May 1, 1979·The Journal of Pediatrics·R R Chilcote, R L Baehner
Dec 29, 1977·The New England Journal of Medicine·W T HughesS L George
Apr 1, 1966·American Journal of Diseases of Children·M FeingoldJ G Tilles
Oct 1, 1971·American Journal of Diseases of Children·I MimicaG W Ledermann
Dec 1, 1983·Proceedings of the Society for Experimental Biology and Medicine·G Schiffman

Citations

Feb 1, 1993·Leukemia & Lymphoma·D Ridgway, L J Wolff
Sep 22, 2009·British Journal of Haematology·Thomas LehrnbecherHans-Jürgen Laws
May 29, 2014·BioMed Research International·Simone CesaroDésirée Caselli
Oct 1, 1997·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·E N Janoff, J B Rubins

Related Concepts

Antibodies, Bacterial
Antineoplastic Chemotherapy Protocols
Bacterial Vaccines
Lymphoid Leukemia
Pneumococcal Infections
Streptococcus pneumoniae
Vaccination

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.